174 related articles for article (PubMed ID: 21506615)
1. Extracting sets of chemical substructures and protein domains governing drug-target interactions.
Yamanishi Y; Pauwels E; Saigo H; Stoven V
J Chem Inf Model; 2011 May; 51(5):1183-94. PubMed ID: 21506615
[TBL] [Abstract][Full Text] [Related]
2. A chemogenomic approach to drug discovery: focus on cardiovascular diseases.
Cases M; Mestres J
Drug Discov Today; 2009 May; 14(9-10):479-85. PubMed ID: 19429507
[TBL] [Abstract][Full Text] [Related]
3. Are target-family-privileged substructures truly privileged?
Schnur DM; Hermsmeier MA; Tebben AJ
J Med Chem; 2006 Mar; 49(6):2000-9. PubMed ID: 16539387
[TBL] [Abstract][Full Text] [Related]
4. iDrug-Target: predicting the interactions between drug compounds and target proteins in cellular networking via benchmark dataset optimization approach.
Xiao X; Min JL; Lin WZ; Liu Z; Cheng X; Chou KC
J Biomol Struct Dyn; 2015; 33(10):2221-33. PubMed ID: 25513722
[TBL] [Abstract][Full Text] [Related]
5. Generalized modeling of enzyme-ligand interactions using proteochemometrics and local protein substructures.
Strömbergsson H; Kryshtafovych A; Prusis P; Fidelis K; Wikberg JE; Komorowski J; Hvidsten TR
Proteins; 2006 Nov; 65(3):568-79. PubMed ID: 16948162
[TBL] [Abstract][Full Text] [Related]
6. Characterizing common substructures of ligands for GPCR protein subfamilies.
Erguner B; Hattori M; Goto S; Kanehisa M
Genome Inform; 2010; 24():31-41. PubMed ID: 22081587
[TBL] [Abstract][Full Text] [Related]
7. The topology of drug-target interaction networks: implicit dependence on drug properties and target families.
Mestres J; Gregori-Puigjané E; Valverde S; Solé RV
Mol Biosyst; 2009 Sep; 5(9):1051-7. PubMed ID: 19668871
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential drug-targets by combining evolutionary information extracted from frequency profiles and molecular topological structures.
Wang L; You ZH; Li LP; Yan X; Zhang W; Song KJ; Song CD
Chem Biol Drug Des; 2020 Aug; 96(2):758-767. PubMed ID: 31393672
[TBL] [Abstract][Full Text] [Related]
9. Prediction of drug target groups based on chemical-chemical similarities and chemical-chemical/protein connections.
Chen L; Lu J; Luo X; Feng KY
Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):207-13. PubMed ID: 23732562
[TBL] [Abstract][Full Text] [Related]
10. Predicting target-ligand interactions using protein ligand-binding site and ligand substructures.
Wang C; Liu J; Luo F; Deng Z; Hu QN
BMC Syst Biol; 2015; 9 Suppl 1(Suppl 1):S2. PubMed ID: 25707321
[TBL] [Abstract][Full Text] [Related]
11. Incorporating chemical sub-structures and protein evolutionary information for inferring drug-target interactions.
Wang L; You ZH; Li LP; Yan X; Zhang W
Sci Rep; 2020 Apr; 10(1):6641. PubMed ID: 32313024
[TBL] [Abstract][Full Text] [Related]
12. Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions.
Strömbergsson H; Prusis P; Midelfart H; Lapinsh M; Wikberg JE; Komorowski J
Proteins; 2006 Apr; 63(1):24-34. PubMed ID: 16435365
[TBL] [Abstract][Full Text] [Related]
13. Conserved core substructures in the overlay of protein-ligand complexes.
Finzel BC; Akavaram R; Ragipindi A; Van Voorst JR; Cahn M; Davis ME; Pokross ME; Sheriff S; Baldwin ET
J Chem Inf Model; 2011 Aug; 51(8):1931-41. PubMed ID: 21736376
[TBL] [Abstract][Full Text] [Related]
14. Protein promiscuity: drug resistance and native functions--HIV-1 case.
Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
[TBL] [Abstract][Full Text] [Related]
15. Chemical genomics approach for GPCR-ligand interaction prediction and extraction of ligand binding determinants.
Shiraishi A; Niijima S; Brown JB; Nakatsui M; Okuno Y
J Chem Inf Model; 2013 Jun; 53(6):1253-62. PubMed ID: 23721295
[TBL] [Abstract][Full Text] [Related]
16. Sparse Modeling to Analyze Drug-Target Interaction Networks.
Yamanishi Y
Methods Mol Biol; 2018; 1807():181-193. PubMed ID: 30030811
[TBL] [Abstract][Full Text] [Related]
17. Predicting drug-target interactions using probabilistic matrix factorization.
Cobanoglu MC; Liu C; Hu F; Oltvai ZN; Bahar I
J Chem Inf Model; 2013 Dec; 53(12):3399-409. PubMed ID: 24289468
[TBL] [Abstract][Full Text] [Related]
18. Protein-ligand interaction prediction: an improved chemogenomics approach.
Jacob L; Vert JP
Bioinformatics; 2008 Oct; 24(19):2149-56. PubMed ID: 18676415
[TBL] [Abstract][Full Text] [Related]
19. Global optimization-based inference of chemogenomic features from drug-target interactions.
Zu S; Chen T; Li S
Bioinformatics; 2015 Aug; 31(15):2523-9. PubMed ID: 25819672
[TBL] [Abstract][Full Text] [Related]
20. Drug-target interaction prediction by random walk on the heterogeneous network.
Chen X; Liu MX; Yan GY
Mol Biosyst; 2012 Jul; 8(7):1970-8. PubMed ID: 22538619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
